Oglasan Xe 0, 5 % w/v Sterile Ophthalmic Solution
PDF Leaflet Revision Date: 04 May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Reduction of elevated intraocular pressure in glaucoma and ocular hypertension.
Dosage (summary)
One drop in affected eye(s) once daily.
Onset of Action / Duration
Onset: 20 mins, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy; contraindicated in breastfeeding.
Key Drug Interactions
- Calcium channel blockers
- Beta-adrenergic blockers
- Antiarrhythmics
Contraindications
- Hypersensitivity
- Asthma
- Bradycardia
- Heart block
- Cardiac failure
Common side effects
- Blurred vision
- Burning
- Stinging
- Dry eyes
Counselling Points
- Monitor for blurred vision
- Avoid contact lens use
- Report any ocular irritation
Serious warnings
- Cardiac failure risk
- Bronchospasm risk
- Masking of hypoglycemia
Important Disclaimer
The Oglasan Xe 0, 5 % w/v Sterile Ophthalmic Solution professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
